Pasithea Therapeutics Corp.KTTAEarnings & Financial Report
Nasdaq
KTTA Q4 2022 Key Financial Metrics
Revenue
$240.7K
Gross Profit
$242.0K
Operating Profit
$-5.1M
Net Profit
$-5.1M
Gross Margin
100.5%
Operating Margin
-2110.8%
Net Margin
-2126.1%
YoY Growth
N/A
EPS
$-0.24
Financial Flow
Pasithea Therapeutics Corp. Q4 2022 Financial Summary
Pasithea Therapeutics Corp. reported revenue of $240.7K for Q4 2022, with a net profit of $-5.1M (-2126.1% margin). Cost of goods sold was $-1.3K, operating expenses totaled $5.3M.
Key Financial Metrics
| Total Revenue | $240.7K |
|---|---|
| Net Profit | $-5.1M |
| Gross Margin | 100.5% |
| Operating Margin | -2110.8% |
| Report Period | Q4 2022 |
Pasithea Therapeutics Corp. Annual Revenue by Year
Pasithea Therapeutics Corp. annual revenue history includes year-by-year totals (for example, 2022 revenue was $486.6K).
| Year | Annual Revenue |
|---|---|
| 2022 | $486.6K |
Income Statement
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Revenue | $13658 | $13581 | $218608 | $240712 |
| YoY Growth | N/A | N/A | 43133.1% | N/A |
Balance Sheet
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Assets | $51.1M | $53.0M | $49.6M | $45.2M |
| Liabilities | $1.1M | $1.6M | $2.8M | $2.7M |
| Equity | $50.0M | $51.5M | $46.8M | $42.5M |
Cash Flow
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Operating CF | $-2.5M | $-2.4M | $-5.2M | $-4.4M |